Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles - Wikidata - awgldk - TriplyDB

Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles

Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles

http://www.wikidata.org/entity/Q33624748

about

Nanocarriers for vascular delivery of antioxidants Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K".Flash nanoprecipitation: particle structure and stability.Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications.Amphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation.Effects of block copolymer properties on nanocarrier protection from in vivo clearance.Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.Optimized zein nanospheres for improved oral bioavailability of atorvastatin Nitric oxide release: part II. Therapeutic applications.Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano Carriers Single-Step Assembly of Multimodal Imaging Nanocarriers: MRI and Long-Wavelength Fluorescence Imaging.Polymer directed self-assembly of pH-responsive antioxidant nanoparticles Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy Formation of stable nanocarriers by in situ ion pairing during block-copolymer-directed rapid precipitation Gelation chemistries for the encapsulation of nanoparticles in composite gel microparticles for lung imaging and drug delivery Nanoparticles as delivery carriers for anticancer prodrugs.Nanocarriers for vascular delivery of anti-inflammatory agents Ionic Flash NanoPrecipitation (iFNP) for the facile, one-step synthesis of inorganic-organic hybrid nanoparticles in water.Human cytosolic glutathione-S-transferases: quantitative analysis of expression, comparative analysis of structures and inhibition strategies of isozymes involved in drug resistance.Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor.Formulation of long-wavelength indocyanine green nanocarriers.Composite fluorescent nanoparticles for biomedical imaging.Nitric oxide release triggered by two-photon excited photoluminescence of engineered nanomaterials.Inducing angiogenesis with the controlled release of nitric oxide from biodegradable and biocompatible copolymeric nanoparticles Aerosol Delivery of Nanoparticles in Uniform Mannitol Carriers Formulated by Ultrasonic Spray Freeze Drying

P2860

Q27027067-C185FC54-6AFE-4739-A17F-88C70C5C0CB2 Q30422929-8883DFBB-2CB6-4CCE-A170-3CA157D6A18B Q30668553-E3AB5A75-7607-43F0-AEBC-513AC4C03AB6 Q33951477-8473A9EC-9F33-4F57-B98B-F77BA2F4AEF8 Q34089117-D1352604-601A-4D4F-BF7D-9DC633113CF9 Q34283992-F69FD814-F75F-4E37-84E9-EB62844E1AE7 Q35179525-EBDDAB99-8FC4-4D21-BD45-7B968EDEDAAE Q35579500-444CBE89-CD4A-4ED9-ABC0-3A2F5AF94F9F Q35658977-8DED8D9C-0B4D-47E9-B4E1-8EC16A965AC8 Q35780982-CB7515F3-D2CC-4ABF-ABA1-67C1FE41D1DD Q35926097-07E0D441-8154-44F5-891E-C8D51521633B Q36176439-3A33320D-9674-45BA-ACCF-11A5A5AC8EF1 Q36198686-0831AE94-A1BE-4B6D-953E-F7BBED2520AF Q36372387-72B5D419-6830-4500-B7C9-97449CE01B87 Q36390180-645BF93D-9AD2-4C6B-94C0-C82E3E8A9035 Q36916351-51E788F3-ADCD-4573-8659-766DA6F09D3F Q37694016-D0F9C04F-5046-476F-85D5-238F20BD94C1 Q38002956-314910CA-E269-4403-830A-C93F2FFAF56E Q38176037-C8BFD762-DB8E-4B1D-97E1-5A699C5CCFFD Q38433917-DDC627CE-4F91-4327-984B-B913FFB1FF73 Q38724701-71923599-773E-437F-8C15-B77252D7FFE1 Q41170076-BE25D7F5-AE4F-4DD5-A8E7-F82CA192BDC7 Q47660849-82A73B68-7B47-4B06-B0B3-874583D96AB0 Q50484676-A24259A7-926F-4A96-A9D8-4006BFA926A6 Q51741120-35889EC4-8101-48E8-ADB4-49EA2C80EB7B Q58555811-FBE79CEF-0874-4738-B97C-E6BB85E698D7 Q59291762-A33ACBDC-89E0-4976-AE5A-97E8DF5679D4

P2860

Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles

http://www.wikidata.org/entity/Q33624748

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Stabilization of the nitric ox ...... to PEG-protected nanoparticles

@ast

Stabilization of the nitric ox ...... to PEG-protected nanoparticles

@en

type

label

Stabilization of the nitric ox ...... to PEG-protected nanoparticles

@ast

Stabilization of the nitric ox ...... to PEG-protected nanoparticles

@en

prefLabel

Stabilization of the nitric ox ...... to PEG-protected nanoparticles

@ast

Stabilization of the nitric ox ...... to PEG-protected nanoparticles

@en

P1433

Q33624748-776507FF-8EA6-40FB-B606-57C8F19B7023

P1476

Q33624748-F32418EC-ACD1-4344-B10B-80C1BBB51B50

P2093

Q33624748-0F04159B-6AE5-4DAA-8523-1B4A731D4FC2

Q33624748-3A1613AB-207F-4163-B40B-EECF8364CEF9

Q33624748-4F644841-3DDF-4279-B964-F921BF10A14B

Q33624748-5DE3E750-57A0-4F7E-961E-32C567C79770

Q33624748-A318EF0E-8E4F-4006-B544-2D3760585848

Q33624748-D0A430B4-8EAA-4B49-A28C-3DD2E165AC00

Q33624748-D99D368C-0979-4E3E-A078-2E8FCFC1FB24

Q33624748-DF1ED858-8B10-432E-8F4D-CF8A744A5464

P2860

Q33624748-0444205F-3649-41E3-B84F-DF6B0D2DBA9E

Q33624748-064D4435-EA49-450C-9903-A1301FAE4A04

Q33624748-09D60397-618F-4F51-9138-89D61E9F7B92

Q33624748-0D75AED3-22FD-4C6B-88AD-D8BCCE24B839

Q33624748-141DFDAB-E380-4E2A-9999-9416862BCC1D

Q33624748-18D3A306-B94A-46F2-861A-75C72ECB061F

Q33624748-1D546B00-8D99-47AC-8012-E5B072455960

Q33624748-22AD08AC-B754-4AF2-BD98-38E82F2B11F0

Q33624748-278D59AE-A7D2-4759-9466-BF92CE1E2A46

Q33624748-28B4ED32-A94B-4EE7-A5CD-A8DF58AB0394

P304

Q33624748-A10039A2-1B51-4116-BC4B-B12E94782F90

P31

Q33624748-3577DA98-2377-4C17-86F8-5CB39F88317F

P356

Q33624748-DC6902BA-F203-4475-BE4C-08DCA70FAF52

P407

Q33624748-BDDD917D-999B-480C-A4D4-9BE82277C492

P433

Q33624748-BD8C8EBA-A6A8-47E6-B985-8D74B3E41FE5

P478

Q33624748-D4B84C9A-5EDC-40EB-984B-C567E65BBC83

P577

Q33624748-68E1FF8B-F575-4108-89D3-A75C140B6F43

P5875

Q33624748-C1D12C63-AA04-4145-B14B-EFBD397D5EFD

P698

Q33624748-BB6C07AE-63BF-4651-AA13-7B4A17A01E92

P921

Q33624748-41B7A5EF-A438-4562-9DFA-41D5E898D501

P932

Q33624748-1F7E87D3-2FD7-4943-B5C9-3683FFB0F5EB

P356

P1433

Molecular Pharmaceutics

P1476

Stabilization of the nitric ox ...... to PEG-protected nanoparticles

@en

P2093

Anna E Maciag

http://www.w3.org/2001/XMLSchema#string

Douglas H Adamson

http://www.w3.org/2001/XMLSchema#string

Harinath Chakrapani

http://www.w3.org/2001/XMLSchema#string

Joseph E Saavedra

http://www.w3.org/2001/XMLSchema#string

Larry K Keefer

http://www.w3.org/2001/XMLSchema#string

Robert K Prud'homme

http://www.w3.org/2001/XMLSchema#string

Sam Y Hong

http://www.w3.org/2001/XMLSchema#string

Varun Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins.

Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone.

Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.

Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.

A novel role for human sulfiredoxin in the reversal of glutathionylation.

JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells.

Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities.

P304

291-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP900245H

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40678781

http://www.w3.org/2001/XMLSchema#string

P698

20000791

http://www.w3.org/2001/XMLSchema#string

P921

P932

2815019

http://www.w3.org/2001/XMLSchema#string